Quick View
| Metric | Current Period | Prior-year Period | YoY |
|---|---|---|---|
| Revenue | ¥344.6B | ¥249.5B | +38.1% |
| Operating Income | ¥27.7B | ¥5.7B | +382.9% |
| Ordinary Income | ¥28.4B | ¥6.1B | +367.6% |
| Net Income | ¥21.5B | ¥4.3B | +397.7% |
| ROE | 9.2% | 2.0% | - |
Executive Summary
FY2026 Q3 results delivered significant increases in both revenue and earnings: Revenue ¥344.6B (YoY +¥95.1B, +38.1%), Operating Income ¥27.7B (YoY +¥22.0B, +382.9%), Ordinary Income ¥28.4B (YoY +¥22.3B, +367.6%), and Net Income ¥21.5B (YoY +¥17.2B, +397.7%). Gross margin improved to 20.4% from the prior year, and operating margin expanded to 8.0% (up +5.7pt from 2.3% a year earlier). With operating leverage driving results, the SG&A ratio declined to 12.3%. Extraordinary Income of ¥4.52B, including ¥3.96B in gains on sale of investment securities, lifted profit before tax to ¥32.4B, and EPS (Basic) reached ¥206.63 (up +¥164.79 from ¥41.84 a year earlier). ROE improved markedly to 9.2%; the DuPont three factors are a net profit margin of 6.2%, total asset turnover of 0.837, and financial leverage of 1.76x. Short-term borrowings fell 96.4% from ¥16.45B in the previous fiscal year to ¥0.60B, the current ratio stands at 170.2%, and with cash and deposits of ¥80.58B, the financial position is sound. By segment, the core Security segment led earnings contribution with revenue of ¥262.7B. The company’s full-year guidance calls for revenue of ¥420.0B (+20.3%), operating income of ¥24.5B, net income of ¥16.0B, and a dividend of ¥33.
Key Financial Metrics
[Profitability] ROE at 9.2% (DuPont three factors: net profit margin 6.2%, total asset turnover 0.837, financial leverage 1.76x) shows a substantial improvement from the prior-year period. Operating margin expanded significantly to 8.0% (improved by +5.7pt from 2.3% a year earlier), and net margin to 6.2% (improved by +4.5pt from 1.7%). Interest coverage is 49.47x, indicating a very light interest burden. [Cash Quality] With cash and deposits of ¥80.58B, cash coverage of short-term borrowings of ¥0.60B is 134.3x. Coverage of current liabilities of ¥107.48B is 0.75x. [Investment Efficiency] Total asset turnover improved YoY to 0.837. Days Sales Outstanding is 45.2 days, and Days Inventory Outstanding is 0.07 days, indicating extremely high inventory efficiency. [Financial Soundness] Equity Ratio 56.8% (+0.8pt from 56.0% a year earlier), Current Ratio 170.2% (improved from 157.7% a year earlier), and Quick Ratio 170.1%, reflecting sound short-term liquidity. Interest-bearing debt is ¥46.03B (breakdown: long-term borrowings ¥45.43B, short-term borrowings ¥0.60B), with a D/E ratio of 0.20, indicating a conservative capital structure. The company holds goodwill of ¥25.88B and intangible assets of ¥35.07B.
Cash Flow Analysis
Cash and deposits increased by +¥4.07B (+5.3%) from ¥76.51B a year earlier to ¥80.58B, suggesting that the significant profit increase contributed to cash accumulation. In working capital efficiency, receivables were ¥42.72B (flat from ¥42.89B a year earlier), and inventories were ¥0.07B (down -42.3% from ¥0.11B a year earlier), indicating further improvement in inventory efficiency. Short-term borrowings were substantially reduced by -96.4%, from ¥16.45B in the previous fiscal year to ¥0.60B, suggesting that the significant increase in operating income and the contribution of extraordinary income facilitated repayment of short-term debt. On the investment side, property, plant and equipment increased by +¥0.65B from ¥73.16B in the previous fiscal year to ¥73.81B, implying capital expenditures exceeding depreciation. Investment securities decreased by -¥3.76B from ¥24.02B in the previous fiscal year to ¥20.26B, consistent with recognition of ¥3.96B in gains on sale. On the financing side, treasury stock increased by -¥0.50B from -¥11.67B in the previous fiscal year to -¥12.17B, suggesting share repurchases. With the substantial compression of short-term borrowings and maintenance of cash, cash coverage of short-term liabilities improved significantly from 4.65x in the previous fiscal year to 134.3x, indicating ample liquidity.
Quality of Earnings
Ordinary Income was ¥28.4B versus Operating Income of ¥27.7B, resulting in net non-operating income of +¥0.77B, which is estimated to consist largely of financial income such as interest and dividends received. Non-operating income/expenses amounted to 0.2% of revenue, indicating a high reliance on core business earnings. Extraordinary gains/losses produced a net surplus of +¥3.88B, mainly due to ¥3.96B in gains on sale of investment securities. Extraordinary Income of ¥4.52B accounted for 13.9% of profit before tax of ¥32.43B, evidencing a clear contribution from one-off factors. At the operating level, operating margin improved substantially to 8.0%, indicating that core business profitability itself has strengthened. While the absence of disclosure on Operating Cash Flow limits assessment on an accrual basis, the buildup of cash balances and the substantial reduction in short-term borrowings support, to a certain extent, the quality of earnings. However, assuming the roll-off of extraordinary gains such as gains on sale of investment securities, caution is warranted regarding the sustainability of net income.
Risk Factors
Sustainability of revenue growth: Whether rapid growth of +38.1% YoY is sustainable depends on order trends and customer concentration. As Q3 progress significantly outpaces full-year guidance (+20.3%), it is necessary to check for Q4 deceleration risks or the presence of any temporary year-end uplift factors. Goodwill and intangible asset impairment risk: The company holds total goodwill of ¥25.88B (6.3% of total assets) and intangible assets of ¥35.07B (8.5% of total assets), a combined ¥60.95B. If the profitability of acquired assets declines, an impairment loss would correspond to approximately 26% of shareholders’ equity of ¥233.95B, necessitating monitoring of investment recovery. Risk of reliance on one-off factors for profits: Extraordinary gains such as ¥3.96B in gains on sale of investment securities account for roughly 18% of current period net income of ¥21.5B; if these roll off, net income could decline significantly. The divergence between full-year guidance for net income of ¥16.0B and Q3 actual of ¥21.5B also suggests such an impact.
Industry Benchmark (Reference; Our Research)
[Position within industry] (Reference information; our research) Profitability: Operating margin of 8.0% exceeds the industry median of 7.1% (2025 Q3, healthcare sector, 56 companies) by +0.9pt, placing the company above the midpoint within the sector. Net margin of 6.2% exceeds the industry median of 5.3% by +0.9pt and is similarly favorable. ROE of 9.2% exceeds the industry median of 6.5% by +2.7pt, reaching a top-tier level within the sector. Efficiency: Total asset turnover of 0.837 slightly exceeds the industry median of 0.81, indicating asset efficiency around the industry average. DSO of 45.2 days is -12.7 days better than the industry median of 57.87 days, showing superior collection efficiency. Soundness: Equity Ratio of 56.8% is almost in line with the industry median of 57.1%, representing standard financial soundness within the sector. Current Ratio of 170.2% (1.70x) is below the industry median of 2.30x, but short-term liquidity remains at a sound level. Growth: Revenue growth of +38.1% significantly exceeds the industry median of +9.1%, achieving remarkable high growth within the sector. EPS growth is +293.8% YoY (EPS ¥41.84 → ¥206.63), far surpassing the industry median of +10.0%. Financial leverage of 1.76x is nearly the same as the industry median of 1.72x, indicating a balanced capital structure. Overall, the company ranks high in profitability and growth within the sector while maintaining standard levels of soundness. Note: Sector: healthcare (56 companies), comparison period: 2025 Q3, Source: Our compilation
Key Takeaways from Results
Significant profitability improvement driven by operating leverage: With revenue up +38.1%, operating margin expanded from 2.3% to 8.0% (+5.7pt), demonstrating pronounced fixed-cost absorption through a lower SG&A ratio. Against full-year guidance for operating income of ¥24.5B, Q3 operating income is already ¥27.7B, a progress rate of 113%, confirming an upside at the operating level. Compression of short-term debt and stronger financial profile: Short-term borrowings were reduced by -96.4% from ¥16.45B in the previous fiscal year to ¥0.60B, and with cash and deposits maintained at ¥80.58B, liquidity improved significantly. This financial restructuring greatly reduced short-term liquidity risk and secured an extremely high interest coverage of 49.47x. One-off contributions and notes on earnings quality: Gains on sale of investment securities of ¥3.96B account for roughly 18% of net income of ¥21.5B. Given that full-year guidance for net income of ¥16.0B is set below the Q3 actual, it is inferred that the company itself is factoring in the roll-off of extraordinary gains. Although the absence of disclosure on Operating Cash Flow constrains confirmation of cash conversion, the accumulation of cash and the compression of short-term borrowings suggest that de facto cash generation capacity is at least solid.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not constitute a recommendation to invest in any specific security. The industry benchmark is reference information compiled by our firm based on publicly available financial statements. Investment decisions are your own responsibility; consult a professional as needed before making any decisions.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 performance was exceptionally strong, with sales growth and a sharp recovery in operating profitability, although reported net income also benefited from securities-sale gains. Revenue rose 38.1% YoY to ¥34.46bn. Operating income increased 382.9% YoY to ¥2.77bn. Ordinary income rose 367.6% to ¥2.85bn. Net income attributable to owners surged 397.7% to ¥2.15bn. Gross profit increased to ¥7.02bn from ¥4.98bn in the prior-year period. The gross margin improved to 20.4% from approximately 19.9%, an expansion of about 44bp. The operating margin widened to 8.0% from approximately 2.3%, a substantial expansion of about 573bp. The net margin rose to 6.2% from approximately 1.7%, up about 451bp. SG&A declined 3.4% YoY to ¥4.25bn despite the 38.1% increase in revenue, demonstrating very strong operating leverage. Operating income growth therefore reflects both improved gross profitability and strong fixed-cost absorption. Non-operating income of ¥0.15bn included ¥0.09bn of dividend income, while interest expense was only ¥0.06bn. Interest coverage was very strong at 49.47x. Profit before tax included a net extraordinary gain of ¥0.40bn, principally a ¥0.40bn gain on sales of investment securities, which enhanced reported net income but is not part of recurring operating performance. The annualized ROE was 12.2%, within the good 10-15% benchmark range, supported primarily by improved profitability rather than aggressive leverage. Q3 cumulative revenue already represents 82.0% of the full-year company forecast, above the standard 75% progress level. Operating income has reached 113.0% of the full-year forecast, ordinary income 111.6%, and net income 134.3%. These progress rates indicate that the current full-year earnings plan is conservative relative to the Q3 result or that management expects a marked Q4 normalization. The ¥65.0 full-year DPS forecast implies a dividend-only payout ratio of approximately 42.2% against forecast EPS of ¥153.89, leaving an apparently sustainable distribution buffer. The balance sheet remains liquid and adequately capitalized, with a 170.2% current ratio and 56.8% equity ratio. Goodwill is moderate relative to equity at 11.1%, limiting the current balance-sheet sensitivity to acquisition-related impairment. The key issue for investors is the durability of the margin recovery and whether the substantial Q3 outperformance will translate into an upward revision of full-year guidance.
Profitability Analysis
The annualized DuPont ROE is 12.2%, decomposed into a 6.2% net profit margin, 1.116x asset turnover, and 1.76x financial leverage. The largest positive change is profitability: operating margin expanded by approximately 573bp YoY to 8.0%, while net margin expanded by about 451bp to 6.2%. Revenue growth of 38.1% substantially outpaced the 3.4% decline in SG&A, producing pronounced operating leverage. Gross margin also improved by about 44bp to 20.4%, indicating that the earnings recovery was not solely a fixed-cost effect. The 8.0% EBIT margin places profitability at the lower end of the stated 8-15% good benchmark range, versus a clearly weak prior-year operating margin near 2.3%. The 1.116x annualized asset-turnover component indicates solid utilization of the ¥41.16bn asset base. Financial leverage of 1.76x is moderate rather than excessive and is not the principal driver of returns. The tax burden was 0.662, reflecting an effective tax rate of 33.8%, while the interest burden exceeded 1.0x because profit before tax was lifted by extraordinary gains relative to EBIT. Dividend income of ¥0.09bn modestly supplemented ordinary earnings. However, a ¥0.40bn net extraordinary gain, mainly from the sale of investment securities, accounted for roughly 18.5% of reported net income. Accordingly, the underlying operating recovery is strong, but reported net-income growth overstates the improvement in recurring earnings to some extent. Under JGAAP, the ¥2.59bn goodwill balance is amortizable and may continue to weigh on reported operating income relative to an IFRS peer, although the available figures do not isolate goodwill amortization.
Growth Assessment
Revenue growth of 38.1% YoY to ¥34.46bn is the central growth achievement, and the simultaneous gross-margin expansion supports the quality of the top-line increase. Operating income growth of 382.9% materially exceeded revenue growth because SG&A fell to ¥4.25bn from ¥4.40bn in the comparable period. This combination suggests a substantial improvement in operating leverage and cost absorption. The forecast calls for full-year revenue of ¥42.00bn, implying that Q4 revenue would be approximately ¥7.54bn to meet the plan. That implied Q4 level is well below the ¥34.46bn already reported cumulatively through Q3, consistent with either seasonal concentration in earlier quarters or a conservative forecast. Full-year operating-income guidance of ¥2.45bn has already been exceeded by ¥0.32bn at Q3. Full-year ordinary-income guidance of ¥2.55bn has been exceeded by ¥0.30bn. Full-year forecast net income of ¥1.60bn has been exceeded by ¥0.55bn. While the scale of outperformance creates scope for upward earnings expectations, the securities-sale gain means net-income upside should be separated from recurring operating upside. Sustainability should be assessed primarily through the continuation of sales momentum, gross margin near 20%, and the ability to maintain SG&A discipline as the business expands.
Financial Health
Liquidity is sound, with current assets of ¥18.29bn against current liabilities of ¥10.75bn, resulting in working capital of ¥7.54bn. The current ratio is 170.2% and the quick ratio is 170.1%, both comfortably above healthy benchmarks. Cash and deposits of ¥8.06bn represent 19.6% of total assets and provide substantial liquidity. Cash is 134.30x reported short-term debt, indicating ample coverage of the short-term-loan balance. The reported debt-to-equity ratio is 0.76x, below the 1.0x conservative benchmark and well below the 2.0x warning threshold. Debt/capital is 16.4%, also comfortably below the 40% investment-grade benchmark. Long-term loans were ¥4.54bn, while current portions of long-term loans were ¥1.80bn and current bonds payable were ¥1.00bn. Cash exceeds these disclosed current financing maturities, reducing refinancing and maturity-mismatch risk. Short-term loans declined 96.4% YoY, from ¥1.65bn to ¥0.06bn, improving the immediate debt profile. Long-term loans also declined from ¥5.33bn to ¥4.54bn, indicating balance-sheet deleveraging. Total equity increased to ¥23.40bn from ¥21.74bn, supported by retained earnings rising to ¥11.10bn from ¥9.51bn. The equity ratio improved to 56.8% from 56.0%. Goodwill was ¥2.59bn, equal to 11.1% of equity and 6.3% of assets, comfortably below M&A-related warning thresholds. Intangible assets were 8.5% of total assets, also below the 20% concentration benchmark. Net defined-benefit liability of ¥0.73bn and lease obligations are additional fixed obligations, but they are modest relative to equity and liquidity.
Notable B/S Changes
Short-term loans: -¥1.59bn (-96.4%) to ¥0.06bn — sharply reduced short-term borrowing improves immediate liquidity and reduces reliance on short-term funding. Current portion of long-term loans: +¥1.20bn to ¥1.80bn — a larger portion of loan maturities is classified as current, but cash of ¥8.06bn provides substantial coverage. Long-term loans: -¥0.89bn (-16.7%) to ¥4.54bn — indicates progress in reducing longer-dated bank borrowing. Bonds payable: -¥1.00bn (-66.7%) to ¥0.50bn — lower bond balances support deleveraging, while ¥1.00bn of current bonds payable should remain a maturity-monitoring item. Cash and deposits: +¥1.16bn (+16.9%) to ¥8.06bn — improved liquidity supports debt servicing, working capital, and shareholder distributions. Accounts receivable: +¥0.84bn (+24.6%) to ¥4.27bn — broadly consistent with strong revenue growth but warrants monitoring for collection quality. Investment securities: +¥0.48bn (+11.5%) to ¥4.64bn — a material 11.3% of total assets and a source of market-value volatility and potential non-recurring gains or losses. Goodwill: -¥0.21bn (-7.4%) to ¥2.59bn — the decline reduces acquisition-accounting exposure; goodwill remains moderate at 11.1% of equity. Retained earnings: +¥1.59bn (+16.7%) to ¥11.10bn — reflects earnings accumulation and strengthens the equity base.
Cash Flow Quality
Operating cash-flow, investing cash-flow, financing cash-flow, capital-expenditure, and free-cash-flow figures are not included in the available financial information. Earnings quality can nevertheless be assessed partially from the income statement. Operating income of ¥2.77bn and ordinary income of ¥2.85bn show that the majority of pre-extraordinary profit was generated from operations rather than from non-operating items. The ¥0.40bn net extraordinary gain from investment-security sales lifted profit before tax and net income and should not be treated as recurring cash-generation capacity. Dividend income of ¥0.09bn was a smaller non-operating contributor. Receivables were ¥4.27bn, or 10.4% of assets, while inventories were immaterial at ¥0.01bn, limiting inventory-related working-capital exposure. Cash and deposits increased to ¥8.06bn from ¥6.89bn YoY, a favorable balance-sheet outcome alongside the earnings increase. Cash-flow quality should therefore be evaluated primarily by whether subsequent disclosures confirm cash conversion of the operating-income recovery and whether receivable growth remains proportionate to revenue growth.
Dividend Sustainability
The company paid an interim Q2 dividend of ¥32.0 per share and forecasts full-year DPS of ¥65.0. The interim dividend represents a calculated 17.0% payout ratio against Q3 cumulative net income. Against forecast EPS of ¥153.89, the full-year ¥65.0 DPS implies a dividend-only payout ratio of approximately 42.2%. This is below the 60% sustainability benchmark and leaves a meaningful earnings retention buffer. The interim DPS also exceeds the prior-period ¥20.0 per-share dividend disclosed for the comparable period, consistent with the earnings recovery. Retained earnings increased 16.7% YoY to ¥11.10bn, reinforcing distribution capacity. Balance-sheet liquidity is supportive, with ¥8.06bn of cash and a 170.2% current ratio. The principal consideration is that a portion of Q3 net income was generated by a ¥0.40bn net extraordinary securities-sale gain; recurring dividend capacity is therefore better judged by operating and ordinary earnings than by reported net income alone. The current ¥65.0 annual DPS forecast appears supportable by forecast earnings and the existing capital structure.
Risk Assessment
Business risks include Margin sustainability risk: the operating margin rose sharply to 8.0% from about 2.3% in the prior-year period; maintaining this improvement depends on sustained sales growth, gross-margin discipline, and continued SG&A control., Guidance-normalization risk: Q3 operating income already equals 113.0% of the full-year forecast, so the market will focus on whether management revises forecasts or anticipates a material Q4 earnings slowdown., Security-services industry risk: demand can be resilient, but labor availability, wage inflation, recruitment costs, and the ability to pass higher personnel costs through to customers can materially affect profitability., Technology and service-delivery risk: security-service operators require continuing investment in monitoring systems, communications infrastructure, software, and equipment; technological obsolescence or execution issues can pressure returns., Goodwill and intangible-asset risk: goodwill of ¥2.59bn and intangible assets of ¥3.51bn require continued economic performance of the underlying acquired or developed businesses..
Financial risks include Non-recurring earnings risk: net extraordinary gains of ¥0.40bn, mainly a ¥0.40bn gain on sales of investment securities, enhanced Q3 profit and are not a recurring earnings source., Refinancing risk is limited but should be monitored: disclosed current portions of long-term loans of ¥1.80bn and current bonds of ¥1.00bn require funding discipline, although cash of ¥8.06bn provides substantial coverage., Market-value risk exists in the ¥4.64bn investment-securities portfolio, as securities valuations and realized gains can affect comprehensive income and non-recurring profit..
Key concerns include No significant quality alerts were identified in the supplied analysis., The most material analytical focus is separating recurring operating improvement from the one-off gain on sale of investment securities., The substantial variance between Q3 cumulative profit and full-year guidance makes the timing and sustainability of earnings the principal near-term issue., Interest coverage of 49.47x, debt/capital of 16.4%, and current and quick ratios above 170% mitigate balance-sheet risk..
Investment Implications
Key takeaways include Revenue increased 38.1% YoY to ¥34.46bn, while operating income rose 382.9% to ¥2.77bn., Operating margin improved by about 573bp YoY to 8.0%, driven by gross-margin improvement and SG&A declining 3.4% despite strong revenue growth., Q3 cumulative operating income exceeded full-year guidance by 13.0%, making guidance treatment and Q4 run-rate central analytical issues., Reported net income includes a ¥0.40bn net extraordinary gain, principally from investment-security sales., Liquidity, leverage, interest coverage, and goodwill exposure all appear within conservative ranges..
Metrics to watch include Quarterly revenue growth and the sustainability of gross margin around 20.4%, Operating margin and SG&A trajectory following the Q3 operating-leverage improvement, Any revision to ¥42.00bn revenue, ¥2.45bn operating income, ¥2.55bn ordinary income, and ¥1.60bn net-income guidance, Recurring earnings excluding gains on investment-security sales, Receivables relative to revenue growth and cash-balance development, Long-term debt and current debt-maturity movements, Goodwill and intangible-asset performance, including any JGAAP amortization or impairment charges.
Regarding relative positioning, On the disclosed financial metrics, the company combines good annualized ROE of 12.2%, an 8.0% operating margin, strong 49.47x interest coverage, conservative 16.4% debt/capital, and moderate 11.1% goodwill/equity. The principal differentiator is the magnitude of operating recovery, while the key qualification is that reported net income is partly supplemented by a non-recurring securities-sale gain.